AstraZeneca taps Chinese biotech in $5.2bn chronic disease research deal
AstraZeneca has joined the long list of big pharma companies enlisting the services of Chinese biotechs, signing a deal worth…
News
Bharat Biotech acquires licence for GSK’s Shigella vaccine development
Moderna’s mRNA RSV vaccine wins expanded FDA approval for younger adults
Debiopharm and Alkyon link for radioligand therapies development
FDA approves label expansion of AbbVie hepatitis C therapy
BioNTech bolsters mRNA pipeline with $1.25bn CureVac acquisition
Wes Streeting: £29bn NHS boost ‘substantial’ but reform still needed
Vaccine sceptics among new members hired by RFK Jr for CDC’s vaccine panel
